Last quarter (Q3 2023), Keros Therapeutics's total revenue was $8.00K, an increase of Infinity% from the same quarter last year. In Q3, Keros Therapeutics's net income was $-39.44M. See Keros Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 8.00K	-	$ 20.10M	$ 0.00	$ 10.00M	$ 10.00M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 8.00K	-	$ 20.10M	-	-	-
Operating Expense	$ 77.72M	$ 114.79M	$ -76.47M	$ 46.66M	$ 20.56M	$ 11.69M
Operating Income	$ -155.45M	$ -114.79M	$ -56.37M	$ -46.66M	$ -10.56M	$ -1.69M
Net Non Operating Interest Income Expense	$ 19.00K	$ -1.00K	$ -4.00K	$ -6.00K	$ -8.00K	$ 6.00K
Other Income Expense	$ -12.98M	$ -10.13M	$ 356.00K	$ 1.13M	$ -1.76M	$ 607.00K
Pretax Income	$ -142.45M	$ -104.68M	$ -56.73M	$ -45.53M	$ -12.34M	$ -1.08M
Tax Provision	-	-	$ 2.01M	$ -172.00K	$ 0.00	$ 257.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -245.47M	$ -104.68M	$ -117.49M	$ -45.36M	$ -14.14M	$ -1.33M
Basic EPS	$ -4.95	$ -4.15	$ -2.52	$ -2.93	$ -1.39	$ -0.15
Diluted EPS	$ -4.95	$ -4.15	$ -2.52	$ -2.93	$ -1.39	$ -0.15
Basic Average Shares	$ 112.88M	$ 25.24M	$ 23.33M	$ 15.51M	$ 8.88M	$ 8.88M
Diluted Average Shares	$ 112.88M	$ 25.24M	$ 23.33M	$ 15.51M	$ 8.88M	$ 8.88M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 77.72M	$ 114.79M	$ -76.47M	$ 46.66M	$ 20.56M	$ 11.69M
Net Income From Continuing And Discontinued Operation	$ -142.45M	$ -104.68M	$ -58.74M	$ -45.36M	$ -12.34M	$ -1.33M
Normalized Income	$ -60.79M	$ -82.70M	-	$ -45.36M	$ -12.34M	$ -1.33M
Interest Expense	-	-	-	$ 6.00K	$ 8.00K	$ -6.00K
EBIT	$ -142.47M	$ -104.68M	$ -56.73M	$ -45.53M	$ -12.33M	$ -1.08M
EBITDA	$ -140.23M	$ -103.06M	$ -55.83M	$ -45.25M	$ -12.12M	$ -931.00K

Currency in USD

Keros Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing